Table 1.
Correlation between EGFRvIII expression and clinical data in 66 patients with glioblastoma multiforme.
| Characteristics | EGFRvIII (−) n = 15 |
EGFRvIII (+) n = 51 |
Variation (p-Value) |
|---|---|---|---|
| Age at diagnosis | 0.2136 a | ||
| Mean | 44.13 | 48.92 | |
| Standard Deviation | 15.50 | 12.18 | |
| Gender | 0.7654 b | ||
| Male | 10 | 30 | |
| Female | 5 | 21 | |
| IDH1 Mutation | 0.9999 b | ||
| Mutation | 2 | 9 | |
| Wildtype | 13 | 42 | |
| Not Available | |||
| 1p/19q Codeletion Status | 0.9999 b | ||
| Codeletion | 0 | 0 | |
| Non-Codeletion | 15 | 50 | |
| Not Available | 0 | 1 | |
| MGMT Promoter Status | 0.2361 b | ||
| Methylated | 4 | 24 | |
| Un-Methylated | 11 | 27 | |
| Not Available | |||
| Radiotherapy | 0.4200 b | ||
| Yes | 12 | 44 | |
| No | 3 | 6 | |
| Not Available | 0 | 1 | |
| Chemotherapy | 0.2825 b | ||
| Yes | 10 | 41 | |
| No | 5 | 9 | |
| Not Available | 0 | 1 |
a Unpaired t test; b Fisher’s exact test.